Introduction {#s1}
============

*Aspergillus fumigatus* is a saprophytic environmental fungus with ubiquitous airborne spores. It is also an opportunistic fungal pathogen responsible for mycoses including invasive aspergillosis (IA) mostly in immunocompromised patients (Van De Veerdonk et al., [@B55]; Fang and Latge, [@B12]). IA is a very severe systemic infection with an estimated global incidence of over 200,000 per annum (Geissel et al., [@B14]) and a mortality rate close to 100% in most groups of patients who did not receive treatment (Darling and Milder, [@B11]). Unfortunately, cases of aspergillosis have also been reported in immunocompetent patients (Stevens and Melikian, [@B46]). The emergence of drug resistant strains to the wide range of currently available drugs has posed a serious challenge as cases are rising globally (Prigitano et al., [@B41], [@B42]; Abdolrasouli et al., [@B1]). Reports of *A. fumigatus* resistance to azole drugs (Hagiwara et al., [@B18]; Sharma et al., [@B45]), polyene drugs such as amphotericin B (Ashu et al., [@B4]), and echinocandin drugs (Beer et al., [@B7]) are increasing in both clinical (Prigitano et al., [@B41]; Abdolrasouli et al., [@B1]; Hagiwara et al., [@B17]) and environmental isolates (Vaezi et al., [@B53]; Prigitano et al., [@B42]). With the limited repertoire of antifungal drug classes, there is therefore the need to urgently discover new therapeutic option for this infection.

Notable strategy will involve studying key virulence factors in suitable model as a tool for understanding pathogenesis as well as screening and testing the efficacy of antifungal agents. *Caenorhabditis elegans* possesses great advantages such as simple life cycle, ease of cultivation and manipulation, relatively low space as well as no ethical requirement, making it an excellent model for a broad range of pathological diseases and infection. Indeed, *C. elegans* has been widely utilized as a host model for pathogenic bacterial infections, such as *C. elegans-Pseudomonas aeruginosa* (Darby et al., [@B10]; Tan et al., [@B50]; Zaborin et al., [@B57]), *C. elegans-Salmonella* spp. (Labrousse et al., [@B29]), *C. elegans-Yersinia pestis* (Styer et al., [@B47]), *C. elegans-Staphylococcus aureus* (Thompson and Brown, [@B52]), *C. elegans-Streptococcus pyogenes* (Jansen et al., [@B23]), and *C. elegans-Acinetobacter baumanii* (Vallejo et al., [@B54]). It has also been adopted for screening of active antimicrobial compounds and discovery of effective agents against several human bacterial (Kong et al., [@B27]; Tharmalingam et al., [@B51]) and fungal pathogens (Tampakakis et al., [@B49]; Okoli et al., [@B38]). Furthermore, *C. elegans* model has been applied for evaluating the pathogenicity of a number of clinically relevant fungal pathogens, including *Candida albicans, Candida krusei, Candida parapsilosis, Candida glabrata* (Breger et al., [@B8]), *Histoplasma capsulatum* (Johnson et al., [@B26]), *Cryptococcus neoformans* (Mylonakis et al., [@B35]), and *Penicillium marneffei* (Huang et al., [@B22]).

Currently *Galleria mellonella* (Gomez-Lopez et al., [@B16]), *Bombyx mori* (Nakamura et al., [@B36]), *Drosophila melanogaster* (Lionakis and Kontoyiannis, [@B30]), mice (Paulussen et al., [@B39]), and guinea pigs (Wiederhold et al., [@B56]) have been utilized as *in vivo* models for *A. fumigatus* infection. On the contrary, little attention has been given to the application of *C. elegans* model in filamentous fungal infections, except for the only report in *A. fumigatus* (Okoli and Bignell, [@B37]). Part of the limitations to its use is that the co-culture technique of infecting *C. elegans* is only suitable for bacterial or dimorphic fungal pathogens but not appropriate for filamentous fungi, as rapid conidia germination and intensive hyphal filamentation would interfere with the survival assessment of worms in killing assay. Despite the fact that Okoli and Bignell have demonstrated the possibility of adopting the *C. elegans* model for *A. fumigatus* infection, further optimization is required to increase the efficiency in worms-spores separation and shorten operation time. This will enable suitable applications of the model in high-throughput screening for novel antifungal compounds, evaluating pathogenicity as well as testing the efficacy of current antifungal agents. In this study, we established a stable and reliable *C. elegans-A. fumigatus* infection model, confirmed by evaluating the pathogenicity of several *A. fumigatus* mutants strains. The model was also optimized for evaluating the efficacy of currently used antifungal agents.

Results {#s2}
=======

Establishment and Optimization of *C. elegans* Model for *A. fumigatus* Infection
---------------------------------------------------------------------------------

*C. elegans* has been successfully utilized as an infection model for several clinically relevant fungal pathogens, such as *C. albicans, C. glabrata, C. neoformans*, and *H. capsulatum* (Mylonakis et al., [@B35]; Breger et al., [@B8]; Johnson et al., [@B26]), but with limited application in filamentous fungal pathogens like *A. fumigatus*. Considering the fast germination feature of *A. fumigatus* in Brain Heart Infusion medium (BHI), we adopted the pre-infection technique on solid plates as described by Okoli and Bignell (35). An extensive washing technique using hand-made device of filter membrane-attached-on-tube was applied to remove conidia that were not ingested by the worms at pre-infection assay. The pre-infection time, conidia concentration for adequate infection and suitable worm numbers for both pre-infection and post-infection were optimized. The whole procedure for establishing the infection model is summarized in [Figure 1](#F1){ref-type="fig"}. Initially two *C. elegans* strains were used as the hosts: the single *fem-3*(q96) mutant which is incapable of producing progeny at 25°C, and the *glp-4*(bn2); *sek-1*(km4) double mutant that is also unable to produce progeny at 25°C as well as being immunocompromised. In order to monitor the conidial ingestion and infection progression stages, we chose *A. fumigatus* Af293-dsRed strain with continuously red fluorescent signal (Jhingran et al., [@B24]), and the widely used parental strain KU80Δ for nematode model establishment ([Table 1](#T1){ref-type="table"}). Both Af293-dsRed and KU80Δ were able to kill and significantly reduce survival rate of *C. elegans fem-3*(q96) strain compared to heat-killed KU80Δ and *Escherichia coli* OP50, the preferred food of nematode (*P* \< 0.0001) ([Figure 2A](#F2){ref-type="fig"}, [Supplementary Table 1](#SM1){ref-type="supplementary-material"}). Interestingly, significant statistical difference was also observed between the survival rates of KU80Δ and Af293-dsRed (*P* \< 0.0001) infections, indicating that Af293-dsRed is less virulent than KU80Δ. Similar susceptibility patterns and statistical values were obtained in the double mutant *glp-4*(bn2); *sek-1*(km4) host ([Figure 2B](#F2){ref-type="fig"}, [Supplementary Table 2](#SM1){ref-type="supplementary-material"}). However, the worm survival rates with Af293-dsRed and KU80Δ in *glp-4*(bn2); *sek-1*(km4) mutant were much lower than that in *fem-3*(q96), demonstrating that the immunocompromised mutant worm is indeed more susceptible to fungal infections. To further substantiate the ability of our *C. elegans-A. fumigatus* infection model to be employed in evaluating pathogenicity of *A. fumigatus* strains, clinical strain Af293, which is also the parental strain of Af239-dsRed, was used for infection. The result showed that this strain displayed the same virulence as the Af293-dsRed strain, but was significantly less virulent than the KU80Δ strain (*P* \< 0.0001) ([Figure 2B](#F2){ref-type="fig"}, [Supplementary Table 2](#SM1){ref-type="supplementary-material"}). After 72 h of killing assay, the survival rates of *glp-4*(bn2); *sek-1*(km4) with Af293-dsRed, KU80Δ and Af293 were reduced to 6, 8, and 5%, respectively ([Supplementary Table 2](#SM1){ref-type="supplementary-material"}). The *glp-4*(bn2);*sek-1*(km4) strain was therefore used as the host strain for all the subsequent experiments.

![Schematic procedure of *C. elegans*-based *A. fumigatus* infection model. Synchronized L4 stage worms were put into NGM plates containing *A. fumigatus* spores at the four edges for 16 h pre-infection. Then extensive washing step was applied to remove conidia that were not ingested by worms. Finally the washed worms were added to BHI medium for killing assay.](fcimb-10-00320-g0001){#F1}

###### 

*A. fumigatus* strains used in this study.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Strain**      **Parent or origin**   **Description**                                                                                                      **References/Sources**
  --------------- ---------------------- -------------------------------------------------------------------------------------------------------------------- ---------------------------------------------
  Af293           Clinical strain        Lab "wild-type" strain                                                                                               FGSC

  Af293-dsRed     Af293                  Red fluorescence in all growth stages\                                                                               Jhingran et al., [@B24]
                                         Same radial growth on Sabouraud plates as Af293                                                                      

  KU80Δ           CEA17                  High frequency of homologous recombination due to the deletion of *KU80* homolog                                     Da Silva Ferreira et al., [@B9]

  Triple *ags*Δ   A1160                  Triple deletion of α-1,3- glucan synthases genes\                                                                    Beauvais et al., [@B6]
                                         Devoid α-(1,3)-glucan in the cell wall\                                                                              
                                         Restructured conidial cell wall\                                                                                     
                                         Less pathogenic in murine aspergillosis model                                                                        

  Δ*pksP*         A1160                  Lacking a functional polyketide synthase PksP, which is responsible for the initial step in DHN-melanin formation\   Bayry et al., [@B5]; Kyrmizi et al., [@B28]
                                         Producing white spores\                                                                                              
                                         Attenuated virulence in murine aspergillosis model                                                                   

  Δ*mrsA*         A1160                  Activated reductive iron assimilation and siderophore-mediated iron acquisition\                                     Long et al., [@B32]
                                         Hypersusceptibility to azole and oxidative stresses\                                                                 
                                         Attenuated virulence in murine aspergillosis model                                                                   

  Δ*leuB*         A1160                  Growth defect that was cured by leucine or iron supplementation\                                                     Long et al., [@B31]
                                         Activation of protease activity and autophagy\                                                                       
                                         Attenuated virulence in *Galleria mellonella*                                                                        

  Δ*tptA*         A1160                  Growth defects and decreased resistance to iron chelator\                                                            Huang et al., [@B21]
                                         Attenuated virulence in murine model                                                                                 

  *Δafmid1*       A1160                  Growth defects, delayed germination, and abnormal morphogenesis\                                                     Jiang et al., [@B25]
                                         Sensitive to oxidative agents\                                                                                       
                                         Enhanced virulence in murine aspergillosis model                                                                     
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

![Survival rate comparison in *C. elegans* hosts. **(A)**, Kaplan-Meier survival plots of *fem-3*(q96) fed by *E.coli* OP50 or conidia of indicated *A. fumigatus* strains. **(B)**, Kaplan-Meier survival plots of *glp-4*(bn2); *sek-1*(km4) fed by *E.coli* OP50 or conidia of indicated *A. fumigatus* strains. Compared to OP50 and dead conidia the Af293-dsRed and KU80Δ strains exhibited significant pathogenicity \[*P* \< 0.0001, Log-rank (Mantel-Cox) test\] in both *fem-3*(q96) and *glp-4*(bn2); *sek-1*(km4) worms. Three biological repeats (each with triplicates) were conducted for each strain.](fcimb-10-00320-g0002){#F2}

Infection and Progression Stages of *A. fumigatus* in *C. elegans*
------------------------------------------------------------------

To understand the infection and progression stages of *A. fumigatus* in *C. elegans*, Af293-dsRed strain was used to infect *glp-4*(bn2); *sek-1*(km4) worms and spores progression was monitored using fluorescence microscope. As shown in [Figure 3](#F3){ref-type="fig"}, the ingestion of conidia was clearly evident throughout the nematode intestine at the beginning of killing assay ([Figure 3](#F3){ref-type="fig"}, [Supplementary Figure 1](#SM1){ref-type="supplementary-material"}). The conidia started to germinate with hyphae protruding from head, body and tail of *C. elegans* by 24 h ([Figure 3](#F3){ref-type="fig"}, [Supplementary Figure 2](#SM1){ref-type="supplementary-material"}). When the killing assay reached 48 h, the hyphae became longer filaments protruding all over the worms\' cuticle ([Figure 3](#F3){ref-type="fig"}, [Supplementary Figure 3](#SM1){ref-type="supplementary-material"}). Furthermore, by 72 h, long hyphae diffused all through the body of the worms, making them appear as "ghosts" bodies ([Figure 3](#F3){ref-type="fig"}). Survival of *C. elegans* was judged mainly by movement and sinusoidal shape as dead worms could not move and appeared straightened or slightly bent in shape, and mostly accompanied with fungal filaments.

![Infection and progression stages of Af293-dsRed in infection to *glp-4*(bn2); *sek-1*(km4) worms. Images were taken under DIC and TRITC channels at killing time of 0, 24, 48, and 72 h. Scale bar is 200 μm.](fcimb-10-00320-g0003){#F3}

Pathogenicity Pattern of *A. fumigatus* Mutant Strains in *C. elegans* Model
----------------------------------------------------------------------------

Following establishing the *C. elegans-A. fumigatus* infection model, we hypothesized that the model would be able to assess the pathogenicity of *A. fumigatus* mutant strains whose virulence have been tested in other infection models. Six mutant strains were collected including triple *ags*Δ mutant, Δ*pksP* mutant, Δ*mrsA* mutant, Δ*leuB* mutant, and Δ*tptA* mutant strains in which attenuated pathogenicity has been previously reported in mice or *G. mellonella* infection models (Pihet et al., [@B40]; Beauvais et al., [@B6]; Long et al., [@B32], [@B31]; Huang et al., [@B21]), and Δ*afmid1* mutant with an augmented virulence reported in mice model (Jiang et al., [@B25]) ([Table 1](#T1){ref-type="table"}). The triple *ags*Δ mutant, obtained by sequential deletions of the three α-1,3 glucan synthase genes (*AGS1, AGS2*, and *AGS3*), is unable to synthesize α-(1, 3)-glucan, a major cell wall polysaccharide component (Henry et al., [@B20]; Beauvais et al., [@B6]). Compared to the parental KU80Δ strain, the triple *ags*Δ mutant displayed significant attenuated virulence (*P* \< 0.0001) with the survival rate of 56 ± 6.9 by 72 h in killing assay ([Figure 4A](#F4){ref-type="fig"}, [Supplementary Table 3](#SM1){ref-type="supplementary-material"}). Δ*pksP* is the knockout strain of polyketide synthase gene *pksp*, which is involved in cell wall melanin synthesis (Pihet et al., [@B40]; Bayry et al., [@B5]). There was statistically significant difference between the virulence of Δ*pksP* mutant and the KU80Δ (*P* \< 0.05), with a higher virulence observed with KU80Δ indicating that this mutant is less virulent than KU80Δ. MrsA and TptA are mitochondrial transporters involved in iron adaptation and homeostasis whereas LeuB is a Zn2Cys6-type transcription factor for leucine biosynthesis and iron acquisition (Long et al., [@B32], [@B31]; Huang et al., [@B21]). Reduced pathogenicity was recorded in our nematode model for Δ*mrsA*, Δ*leuB*, and Δ*tptA* strains, with high significant difference (*P* \< 0.0001) when compared to KU80Δ ([Figure 4A](#F4){ref-type="fig"}, [Supplementary Table 3](#SM1){ref-type="supplementary-material"}). However, Δ*afmid1* strain, which is devoid of the plasma ion channel for replenishing extracellular calcium (Jiang et al., [@B25]), showed no significant virulence difference with KU80Δ (*P* \> 0.05) ([Figure 4A](#F4){ref-type="fig"}, [Supplementary Table 3](#SM1){ref-type="supplementary-material"}). This observation is in contrast to its enhanced pathogenicity above KU80Δ reported in murine model (Jiang et al., [@B25]). Among the mutant strains, the triple *ags*Δ is the least virulent, followed by Δ*tptA* and Δ*leuB* strains, and then the less attenuated Δ*pksP* and Δ*mrsA* strains. Interestingly, the hyphal filamentation rates at 24 h of killing assay followed the same pattern as the survival rates. The Δ*afmid1* mutant and the parental strain KU80Δ had the highest filamentation rate whereas the triple *ags*Δ mutant had the least ([Figure 4B](#F4){ref-type="fig"}, [Supplementary Table 3](#SM1){ref-type="supplementary-material"}). It was observed that the more virulent the strain is, the higher the hyphal filamentation rate, suggesting that the death of the infected worms was mainly due to the germination and hyphal growth of conidia inside the worms which eventually led to puncture of worms when the filaments started to protrude. We noted that the filamentation of these mutant strains in *C. elegans* model did not correlate with *in vitro* growth in BHI medium, of which the triple *ags*Δ mutant exhibited the fastest germination, followed by KU80Δ, Δ*pksp*, Δ*leuB*, and Δ*afmid1* mutant strains, while the Δ*mrsA* and Δ*tptA* mutant strains were the slowest ([Supplementary Figure 4](#SM1){ref-type="supplementary-material"}).

![Survival curve and hyphal filamentation rate of *A. fumigatus* mutant strains in *C. elegans* model. **(A)**, Kaplan-Meier survival plots of *glp-4*(bn2); *sek-1*(km4) on solid BHI plates after 16 h pre-infection with conidia of indicate *A. fumigatus* mutant strains. **(B)**, Hyphal filamentation rates resulting from infection by indicated *A. fumigatus* mutant strains at 24 h in killing assay. Three biological repeats (each with triplicates) were conducted for each strain. One-way ANOVA was used for statistical analysis of filamentation rate, where *p* \> 0.05 showing not significant, ns; *p* ≤ 0.0001 showing highly significant, \*\*\*\*, compared to the KU80Δ strain.](fcimb-10-00320-g0004){#F4}

Evaluation of Antifungal Drug Efficacy in *C. elegans-A. fumigatus* Infection Model
-----------------------------------------------------------------------------------

Having established and confirmed the virulence pattern of our *C. elegans*-*A. fumigatus* infection model, the next challenge was to determine if clinically used antifungal drugs could rescue the aspergillosis infection and death in the nematode model. To achieve a uniformity exposure of the worms to the antifungals as well as ensure sufficient bioavailability of the drug, we optimized the pre-infection time for the liquid killing assay. Pre-infections of 8, 12, and 16 h on solid medium were tested and 8 h was chosen as the best duration for the worms to ingest sufficient conidia while also allowing adequate antifungal treatment test. Amphotericin B (AmB), itraconazole (ItrZ), and voriconazole (VoZ) were used in our *C. elegans* antifungal assay since they are the three commonly used drugs for aspergillosis treatment in clinical settings. All the three drugs showed excellent efficacy and increased the survival of infected worms when compared to the DMSO control treatments. AmB exhibited statistically significant rescue at concentration of 1 μg/ml or higher when compared to DMSO control (*P* \< 0.0001) ([Figure 5A](#F5){ref-type="fig"}, [Supplementary Table 4](#SM1){ref-type="supplementary-material"}). Similar significant rescue was obtained for ItrZ and VoZ at ≥2 μg/ml and ≥0.5 μg/ml, respectively, compared to DMSO control (*P* \< 0.0001) ([Figures 5B,C](#F5){ref-type="fig"}, [Supplementary Tables 5](#SM1){ref-type="supplementary-material"}, [6](#SM1){ref-type="supplementary-material"}). The rescue effects of these antifungal drugs illustrated that our *C. elegans-A. fumigatus* infection model is suitable for evaluating antifungal drug efficacy.

![Kaplan-Meier survival plots of *C. elegans* infected by KU80Δ in the presence of antifungal drugs. The *glp-4*(bn2); *sek-1*(km4) worms were pre-infected with KU80Δ for 8 h then transferred into liquid killing media containing different concentrations of AmB **(A)**, VoZ **(B)**, and ItrZ **(C)**. Three biological repeats (each with triplicates) were conducted for each concentration.](fcimb-10-00320-g0005){#F5}

Killing Mode of Antifungal Drugs in *C. elegans-A. fumigatus* Infection Model
-----------------------------------------------------------------------------

To analyze the killing mode of the antifungal drugs in *C. elegans-A. fumigatus* infection model, Af293-dsRed strain was used for infection of *glp-4*(bn2);*sek-1*(km4) worms. As shown in [Figure 6](#F6){ref-type="fig"}, worms treated with DMSO had hyphal filaments protruding from their cuticles even at 24 h in killing assay. The fungal load from worms treated with the three drugs was significantly reduced as shown from the worm numbers with fluorescent signals ([Figure 6](#F6){ref-type="fig"}). Moreover, dead worms from the AmB treated group possessed advanced hyphal growth whereas dead worms from ItrZ or VoZ treated group had strong accumulated fluorescent signals inside the body but without protruding hyphal filaments ([Figure 6](#F6){ref-type="fig"}). It is interesting to note that ItrZ and VoZ exhibited superior antifungal activity against *A. fumigatus* by preventing the hyphal growth in *C. elegans* model when compared to AmB treatment.

![Effect of antifungal treatment on Af293-dsRed infection to *glp-4*(bn2); *sek-1*(km4) worms. Images were taken under DIC and TRITC channels from DMSO treatment by 24 h, 1.5 μg/ml AmB treatment by 48 h, 2 μg/ml ItrZ treatment by 72 h and 0.5 μg/ml VoZ treatment by 72 h. Scale bar is 200 μm.](fcimb-10-00320-g0006){#F6}

Discussion {#s3}
==========

*C. elegans* as a model organism has been applied for evaluating pathogenicity, studying host-pathogen interactions, testing the efficacy of potential anti-infective compounds, and screening new antimicrobial agents against pathogenic bacteria and fungi. Okoli and Bignell had initially reported that *C. elegans-*based infection model could be applied to the filamentous fungus *A. fumigatus* (Okoli and Bignell, [@B37]). However, sufficient details on the infection process has not been provided to validate the model.

In this study through a series of optimization trials we developed a stable and efficient *C. elegans-A. fumigatus* infectious model. At the beginning of setting up the infection of the worms with *A. fumigatus* spores, fluorescence imaging showed that each of the single and double mutant worms all ingested varying amount of conidia. In addition to this challenge, it was also laborious and difficult to count the exact spore numbers from 100 or 1,000 of worms, which would involve crushing the worms and separating spores from worm lysate for counting. However, we noticed that the conidia concentration, worm numbers and the pre-infection time affected the amount of ingested fungal spores and survival of worms. Therefore, we standardized the concentration of spores and worm numbers, fixed the pre-infection time as 16 h for pathogenicity evaluation and applied conidia in four different points on the pre-infection plates to enhance the chances of conidia ingestion by the worms. As shown in [Supplementary Tables 1--6](#SM1){ref-type="supplementary-material"}, the survival rate of worms in killing assay displayed acceptable standard deviations from three biological repeats of each with triplicates, confirming the repeatability of the infection assay using our optimized protocol even if each worm may not ingest the same amount of spores. A device of filter membrane-attached-on-tube was developed to allow fast extensive worms-spores separation washing, thereby enabling better removal of conidia that were not ingested by the worms. The extensive washing after pre-infection also assisted easier observation of the killing assay without much obstruction from *in vitro* aggressive hyphal growth ([Figure 1](#F1){ref-type="fig"}). Fluorescent Af293-dsRed strain provided further support to our findings that infection could emanate from any part of the worms including head, neck, abdomen, and tail regions through hyphal filaments protrusion ([Figure 3](#F3){ref-type="fig"}), not only through the tail region as initially reported (Okoli and Bignell, [@B37]).

Previous studies have demonstrated that hyphal filamentation is an important virulence factor in fungal pathogenicity in mammal (Mitchell et al., [@B34]; Ariyachet et al., [@B3]; Ghosh et al., [@B15]) and nematode models (Breger et al., [@B8]; Pukkila-Worley et al., [@B44]; Huang et al., [@B22]). Similarly, in our *C. elegans-A. fumigatus* infection model, the *in vivo* germination and growth of conidia into filaments led to the quick death of worms (as the epidermal cuticles were disrupted) as well as limited worm\'s movement due to worm-hyphae adhesion to the medium surface. In both the single and double mutant worms, strain KU80Δ exhibited higher virulence than Af293 and Af293-dsRed strain, corresponding to higher hyphal filamentation rate at 24 h in killing assay ([Figure 2](#F2){ref-type="fig"}, [Supplementary Tables 1](#SM1){ref-type="supplementary-material"}, [2](#SM1){ref-type="supplementary-material"}). To further corroborate the role of hyphal filamentation in the virulence of *A. fumigatus* in *C. elegans*, our results from heat-killed conidia gave no hyphal filamentation as expected and displayed no difference from *E.coli* OP50 with regard to the survival rate of worms ([Figure 2](#F2){ref-type="fig"}, [Supplementary Tables 1](#SM1){ref-type="supplementary-material"}, [2](#SM1){ref-type="supplementary-material"}).

Assessing the pathogenicity of *A. fumigatus* strains is one of the main objective of setting up the nematode model. Among the selected six *A. fumigatus* mutant strains, triple *ags*Δ mutant, Δ*pksP*, Δ*mrsA*, and Δ*tptA* mutants all displayed significant attenuated virulence compared to the parental KU80Δ strain ([Figure 4](#F4){ref-type="fig"}), consistent with their virulence patterns already shown in immunocompromised murine model of aspergillosis (Beauvais et al., [@B6]; Bayry et al., [@B5]; Long et al., [@B32]; Huang et al., [@B21]). Similar attenuated virulence was obtained for Δ*leuB* mutant in our *C. elegans* model which is in agreement with previously described pathogenicity pattern in *G. mellonella* model (Long et al., [@B31]). An exception was the Δ*afmidl* mutant which was hypervirulent in murine model (Jiang et al., [@B25]) but exhibited no significant difference in our *C. elegans* model when compared to the KU80Δ strain. Currently we could not explain why Δ*afmidl* virulence was not enhanced in *C. elegans* model but we strongly suspect that it could be due to the vast differences in *in vivo* environment between the nematode and mice, including the immune system and concentration of calcium ion, which requires further investigation. Again the correlation between virulence and hyphal filamentation was confirmed in infections caused by the six mutant strains ([Figure 4B](#F4){ref-type="fig"}, [Supplementary Table 3](#SM1){ref-type="supplementary-material"}). However, it is noteworthy that some *A. fumigatus* strains, such as the Δ*leuB* and Δ*tptA* mutant strains, did not produce much filamentation at 24 h but eventually became relatively virulent by 72 h in killing assay, implying that hyphal filamentation is not the sole factor responsible for virulence, which further buttresses the need for molecular characterization. To the best of our knowledge, this is the first time that the pathogenicity of *A. fumigatus* strains in *C. elegans* infection model is being compared with that from other animal models. Our stable and reliable nematode infection model would be suitable for evaluating the virulence of more *A. fumigatus* mutant strains, such as mutants from the ongoing COFUN project, which plans to generate knockout mutants of all the coding genes in *A. fumigatus* (<https://www.phe-culturecollections.org.uk/products/fungi/cofun-aspergillus-fumigatus-gene-wide-knock-out-collection.aspx>).

The major drawbacks of the nematode model system include the inability to culture at 37°C and the absence of an adaptive immune response. Even the innate immune responses against pathogenic organisms in murine and *C. elegans* are different. Unlike in mammalian systems in which the transcription factor NF-κB, the Toll-like receptor (TLR) adaptor protein MYD88 and other components of the TLR signaling pathway are key to the innate immune system, *C. elegans* lacks these components. The *C. elegans* immune system however, mounts several conserved signaling pathways, including the p38 mitogen activated protein kinase (MAPK) cassette, the transforming growth factor (TGFβ), the insulin-like DAF-2-DAF-16, as well as the bZIP transcription factor ZIP-2 to defend against pathogens (Pukkila-Worley and Ausubel, [@B43]). Nevertheless, it is still unclear what the exact pathogenic triggers are and how the *C. elegans* detected and responded to pathogens. In murine model, the conidial cell wall of the triple *ags*Δ mutant was covered by a glycoprotein matrix, and PAMPs such as chitin and β-glucan were exposed, thus stimulating host immune response, which led to reduced virulence (Beauvais et al., [@B6]). Attenuated virulence of the Δ*pksp* mutant in murine aspergillosis model is reported to be due to β-glucan exposure and the activated autophagy pathway of the LC3-associated phagocytosis (LAP) (Akoumianaki et al., [@B2]). The immune responses caused by the other four mutant strains are not clear yet in murine or *G. mellonella* models. Nevertheless, it will be desirable to uncover the immune defense of *C. elegans* in more detail by combining histological dissection of intestine epithelium cell structure and global transcription analysis of worms infected by KU80Δ and those mutant strains, particularly by the triple *ags*Δ mutant and the Δ*pksp* mutant.

*C. elegans* model has been utilized in the evaluation of the efficacy of antifungal agents against infections caused by dimorphic fungi, such as *C. albicans, C. krusei, C. parapsilosis*, and *P. marneffei* (Breger et al., [@B8]; Huang et al., [@B22]) but not with the filamentous fungus, *A. fumigatus*. We have also demonstrated the possibility of adopting the *C. elegans* model for *in vivo* evaluation of antifungal agents on nematode aspergillosis. Shorter pre-infection time and liquid killing medium were applied in the assay to assess drug effectiveness. The minimum treatment doses of AmB, ItrZ, and VoZ in *C. elegans* were 1, 2, and 0.5 μg/ml, respectively, close to the *in vitro* MIC values of the tested antifungal drugs (Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing, [@B48]). The evaluation assay can easily be scaled up from 24-well-plates to 96-well or 384-well-plates for high-throughput screening of other bioactive compounds against *A. fumigatus*. Interestingly the killing mode of antifungal drugs in *C. elegans* model was different from that in the *in vitro* culture. The macrolide polyene AmB is a well-known broad-spectrum fungicidal agent (Hamill, [@B19]; Ashu et al., [@B4]) while azole drugs, i.e., VoZ and ItrZ, are mainly fungistatic against *A. fumigatus* (Meletiadis et al., [@B33]). However, visible hyphal filamentation from a number of infected worms graduated to "ghost stage" under AmB treatment whereas only diffused internal hyphal growth and early germinated conidia were observed from worms treated with VoZ and ItrZ ([Figure 6](#F6){ref-type="fig"}). This is suggestive that VoZ and ItrZ may be an attractive alternative to AmB in treatment of invasive pulmonary aspergillosis and reducing occurrence of disseminated aspergillosis in *in vivo* applications.

In summary, our established *C. elegans*-*A. fumigatus* infection model could serve as a preliminary screening for pathogenic phenotypes of *A. fumigates* strains. The application of this model to evaluate the efficacy of antifungal agents on nematode aspergillosis could be the groundwork to develop future antifungal agents against *A. fumigatus*.

Materials and Methods {#s4}
=====================

Strains, Media, and Culture Conditions
--------------------------------------

The *A. fumigatus* strains used in this study are summarized in [Table 1](#T1){ref-type="table"}. The strains were grown on *A. fumigatus* complete medium (Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing, [@B48]) slants composed of 1 g/l yeast extract, 2 g/l peptone, 10 g/l glucose, 1.5 g/l casein hydrolysate acid, 1 ml/l trace element solution, 20 ml/l 50X salt solution. After incubation at 37°C for 24--72 h (depending on mutant strains) conidia were harvested with 0.2% (v/v) Tween 20 aqueous solution, centrifuged and then Tween 20 aqueous solution was decanted out. The conidia were then re-suspended in M9 buffer and standardized to 1.25 × 10^8^ spores/ml in Eppendorf tube.

The *C. elegans* strains *fem-3*(q96) and *glp-4*(bn2); *sek-1*(km4) were used in this study. The *fem-3*(q96) and *glp-4(bn2)* mutations are temperature sensitive and thus prevents them from producing progeny at 25°C while the *sek-1*(*km4*) mutation makes the worms immunocompromised. Worms were grown at 15°C in 90 mm Nematode Growth Medium (Fedorova et al., [@B13]) plates seeded with *E. coli* OP50.

Setting up *C. elegans-A. fumigatus* Infection Model
----------------------------------------------------

NGM medium plus antibiotics (NGM+) was used for pre-infection assay according to methods modified from Okoli and Bignell ([@B37]). Ampicillin, streptomycin, and kanamycin were added to NGM at 100, 100, and 45 μg/ml, respectively. Unstarved worms for at least three generations were filtered through 11 μm pore-sized membrane filter (Merck Millipore Ltd.) using M9, to collect L1 worms for synchronization. Filtrated L1 worms were spread on NGM plates seeded with OP50, and then incubated at 25°C for 48 h for synchronization.

Synchronized L4 worms were washed off from the NGM plates with M9 and transferred to 50 ml tube to sediment for 10 min. The M9-OP50 mix was gently removed using micropipette. Three more sedimentation washes were performed and then standardized worms (about 200--500) were dispensed into triplicate 90 mm NGM+ plates and gently spread to dry. Worms were allowed to move around on the plates for 30 min before 25 μl of standardized conidia (1.25 × 10^8^ spores/ml) were added at the four cardinal points of each NGM+ plates making a total of 100 μl conidia per plate. The plates were then incubated at 25°C for 16 h pre-infection period to allow worms ingest conidia. Control was setup with OP50 instead of conidia.

A 30% Brain Heart Infusion (BHI) plus 200 μg/ml ampicillin, 200 μg/ml streptomycin, and 90 μg/ml kanamycin in M9 solid medium (referred to as BHI+S) was used for solid killing assay. Pre-infected worms were washed off with M9 into 50 ml tube. Then we developed a hand-made "filter membrane-attached-on-tube" device with a 35 μm pore-sized membrane (Sango Biotech) designed into 15 ml Eppendorf tubes to wash out conidia that were not ingested by worms. The filter separated conidia that were not ingested from *C. elegans* to drastically reduce the amount of conidia that would otherwise interfere with the experiment when germinated on BHI+S plates. About 80--200 washed worms were dispensed into 90 mm BHI+S plates in triplicates. Living and dead worms with or without hyphal filament were recorded at 24 h in killing assay using dissecting microscope (Motic SMZ-168 series) whereas only dead and living worm numbers were recorded at 48 and 72 h of killing assay.

Microscopic Imaging
-------------------

We used two approaches to prepare our worms for fluorescent microscopy. The first approach majorly applied to worms at 0 h in killing assay (immediately after 16 h of pre-infection). We made 2% agarose pad on slides and used worm picker to randomly collect worms from BHI+S plates. Worms were transferred to the agarose gel in M9 plus levamisole, then observed and recorded under both fluorescence and DIC channels of Leica upright microscope (Leica Microsystems, STP 8000). The second approach involved cutting out and transferring the BHI+S agar with worms to slides between 24 and 72 h in killing assay. This was very necessary as protrusion of hyphal filaments made worms attached to the medium.

The Procedure for Evaluating Antifungal Drugs Efficacy
------------------------------------------------------

The 8 h Pre-infection time and liquid killing assay were chosen for antifungal drugs evaluation and BHI+S without agar (referred to as BHI+L) was used as the killing medium. Amphotericin B, itraconazole, and voriconazole (MedChemExpress) were prepared in DMSO and diluted to 20 μg/ml with BHI+L (referred to as BHI+L+). Antifungal drug concentrations ranging from 0.5 to 2.0 μg/ml for amphotericin B, 1.0--2.0 μg/ml for voriconazole, and 1.0--10 μg/ml for itraconazole were utilized in 24-well-plates. BHI+L+ were dispensed into triplicates of 24-well-plates to a volume of 320 μl. Then 80 μl of pre-infected worms (\~30--60) were added into each well to make the final volume of 400 μl. DMSO was used as control. Dead and living worm numbers were recorded using Leica inverted microscope (Leica DMC 5400). Antifungal phenotypic images were captured by the inverted microscope under both fluorescent and DIC channels.

Data Analysis
-------------

All infection experiments were performed in triplicates and all the experimental numerical data were expressed as the means ± S.D. The Kaplan-Meier survival curves were plotted by GraphPad Prism 7.0. Statistical *P-*values for survival rates were calculated by Log-rank (Mantel-Cox) test. One-way ANOVA was used for statistical analysis of filamentation rates. Images analysis were performed using ImageJ software.
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